QTTB Q4 2018 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$980,000

Gross Profit

$00.0% margin

Operating Income

-$20M-2080.4% margin

Net Income

-$19M-1939.0% margin

EPS (Diluted)

$-9.16

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$24M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$259M

Total Liabilities

$64M

Stockholders' Equity

$195M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$980,000	$0	—
Gross Profit	$0	-$200,825	+100.0%
Operating Income	-$20M	-$12M	-66.3%
Net Income	-$19M	-$12M	-59.6%